Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.

Yetukuri L, Katajamaa M, Medina-Gomez G, Seppänen-Laakso T, Vidal-Puig A, Oresic M.

BMC Syst Biol. 2007 Feb 15;1:12.

2.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
3.

Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes.

Eisinger K, Krautbauer S, Hebel T, Schmitz G, Aslanidis C, Liebisch G, Buechler C.

Exp Mol Pathol. 2014 Aug;97(1):37-43. doi: 10.1016/j.yexmp.2014.05.002. Epub 2014 May 14.

PMID:
24830603
4.

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.

Monsénégo J, Mansouri A, Akkaoui M, Lenoir V, Esnous C, Fauveau V, Tavernier V, Girard J, Prip-Buus C.

J Hepatol. 2012 Mar;56(3):632-9. doi: 10.1016/j.jhep.2011.10.008. Epub 2011 Oct 25.

PMID:
22037024
5.

Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.

Perfield JW 2nd, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS.

J Obes. 2013;2013:296537. doi: 10.1155/2013/296537. Epub 2013 Jan 16.

6.

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.

Diabetes. 2006 Aug;55(8):2159-70.

7.

Effects of bile acid sequestration on hepatic steatosis in obese mice.

Solís N, Pizarro M, Quintero P, Arab JP, Riquelme A, Padilla O, Carrasco G, Pirola CJ, Sookoian S, Arrese M.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):105-12.

8.

Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders.

Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J.

Hepatology. 2008 May;47(5):1513-23. doi: 10.1002/hep.22220.

PMID:
18393289
9.

Simulation of triacylglycerol ion profiles: bioinformatics for interpretation of triacylglycerol biosynthesis.

Han RH, Wang M, Fang X, Han X.

J Lipid Res. 2013 Apr;54(4):1023-32. doi: 10.1194/jlr.M033837. Epub 2013 Jan 30.

10.

Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice.

Everitt H, Hu M, Ajmo JM, Rogers CQ, Liang X, Zhang R, Yin H, Choi A, Bennett ES, You M.

Am J Physiol Gastrointest Liver Physiol. 2013 Jan 1;304(1):G38-47. doi: 10.1152/ajpgi.00309.2012. Epub 2012 Nov 8.

11.

A novel aminosterol reverses diabetes and fatty liver disease in obese mice.

Takahashi N, Qi Y, Patel HR, Ahima RS.

J Hepatol. 2004 Sep;41(3):391-8.

PMID:
15336441
12.

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.

Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.

Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.

13.

Bioinformatics and computational methods for lipidomics.

Niemelä PS, Castillo S, Sysi-Aho M, Oresic M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2855-62. doi: 10.1016/j.jchromb.2009.01.025. Epub 2009 Jan 24. Review.

PMID:
19200789
14.

High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry.

Ståhlman M, Ejsing CS, Tarasov K, Perman J, Borén J, Ekroos K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2664-72. doi: 10.1016/j.jchromb.2009.02.037. Epub 2009 Feb 24. Review.

PMID:
19286428
15.

Lipidomic analysis of signaling pathways.

Wakelam MJ, Pettitt TR, Postle AD.

Methods Enzymol. 2007;432:233-46.

PMID:
17954220
16.

Lipidomics: practical aspects and applications.

Wolf C, Quinn PJ.

Prog Lipid Res. 2008 Jan;47(1):15-36. Epub 2007 Sep 20. Review.

PMID:
17980916
17.

Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity.

Wendel AA, Li LO, Li Y, Cline GW, Shulman GI, Coleman RA.

Diabetes. 2010 Jun;59(6):1321-9. doi: 10.2337/db09-1380. Epub 2010 Mar 3.

18.

Informatics and computational strategies for the study of lipids.

Orešič M.

Biochim Biophys Acta. 2011 Nov;1811(11):991-9. doi: 10.1016/j.bbalip.2011.06.012. Epub 2011 Jun 25. Review.

PMID:
21708283
20.

Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity.

Kawasaki K, Abe M, Tada F, Tokumoto Y, Chen S, Miyake T, Furukawa S, Matsuura B, Hiasa Y, Onji M.

Lab Invest. 2013 Mar;93(3):311-21. doi: 10.1038/labinvest.2012.176. Epub 2013 Jan 14.

Supplemental Content

Support Center